vs
Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $35.2M, roughly 1.2× NATIONAL RESEARCH CORP). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -17.2%, a 22.4% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -4.6%). NATIONAL RESEARCH CORP produced more free cash flow last quarter ($6.1M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
NRC vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $41.8M |
| Net Profit | $1.8M | $-7.2M |
| Gross Margin | — | 52.0% |
| Operating Margin | 13.3% | -12.1% |
| Net Margin | 5.1% | -17.2% |
| Revenue YoY | -4.6% | 85.7% |
| Net Profit YoY | -72.6% | 43.2% |
| EPS (diluted) | $49.58 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $41.8M | ||
| Q3 25 | $34.6M | $37.3M | ||
| Q2 25 | $34.0M | $38.1M | ||
| Q1 25 | $33.6M | $32.0M | ||
| Q4 24 | $36.9M | $22.5M | ||
| Q3 24 | $35.8M | $18.5M | ||
| Q2 24 | $35.0M | $16.4M | ||
| Q1 24 | $35.3M | $17.4M |
| Q4 25 | $1.8M | $-7.2M | ||
| Q3 25 | $4.1M | $-9.0M | ||
| Q2 25 | $-106.0K | $-10.1M | ||
| Q1 25 | $5.8M | $-12.7M | ||
| Q4 24 | $6.6M | $-12.7M | ||
| Q3 24 | $5.7M | $-13.3M | ||
| Q2 24 | $6.2M | $-9.8M | ||
| Q1 24 | $6.4M | $-7.9M |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | 45.9% | ||
| Q2 25 | — | 46.6% | ||
| Q1 25 | — | 49.2% | ||
| Q4 24 | — | 66.2% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.0% | ||
| Q1 24 | — | 75.1% |
| Q4 25 | 13.3% | -12.1% | ||
| Q3 25 | 22.4% | -19.6% | ||
| Q2 25 | 4.7% | -21.1% | ||
| Q1 25 | 25.6% | -34.4% | ||
| Q4 24 | 26.0% | -51.0% | ||
| Q3 24 | 22.3% | -41.7% | ||
| Q2 24 | 25.3% | -51.7% | ||
| Q1 24 | 24.8% | -39.4% |
| Q4 25 | 5.1% | -17.2% | ||
| Q3 25 | 11.9% | -24.3% | ||
| Q2 25 | -0.3% | -26.6% | ||
| Q1 25 | 17.2% | -39.6% | ||
| Q4 24 | 17.8% | -56.4% | ||
| Q3 24 | 15.9% | -72.0% | ||
| Q2 24 | 17.6% | -59.8% | ||
| Q1 24 | 18.0% | -45.2% |
| Q4 25 | $49.58 | $-0.10 | ||
| Q3 25 | $0.18 | $-0.13 | ||
| Q2 25 | $-0.01 | $-0.15 | ||
| Q1 25 | $0.25 | $-0.21 | ||
| Q4 24 | $0.27 | $-0.34 | ||
| Q3 24 | $0.24 | $-0.44 | ||
| Q2 24 | $0.26 | $-0.33 | ||
| Q1 24 | $0.27 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $14.0M | $22.4M |
| Total Assets | $134.9M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $28.1M | ||
| Q3 25 | $2.2M | $28.0M | ||
| Q2 25 | $5.3M | $11.0M | ||
| Q1 25 | $2.5M | $20.2M | ||
| Q4 24 | $4.2M | $18.5M | ||
| Q3 24 | $3.5M | $20.9M | ||
| Q2 24 | $485.0K | $42.6M | ||
| Q1 24 | $1.7M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | $48.7M | $46.0M | ||
| Q2 24 | $33.3M | $59.8M | ||
| Q1 24 | $35.2M | $59.4M |
| Q4 25 | $14.0M | $22.4M | ||
| Q3 25 | $14.3M | $27.4M | ||
| Q2 25 | $21.3M | $27.1M | ||
| Q1 25 | $29.7M | $35.5M | ||
| Q4 24 | $31.3M | $27.7M | ||
| Q3 24 | $34.6M | $9.4M | ||
| Q2 24 | $40.2M | $19.4M | ||
| Q1 24 | $36.9M | $27.7M |
| Q4 25 | $134.9M | $141.6M | ||
| Q3 25 | $135.7M | $145.5M | ||
| Q2 25 | $141.4M | $134.7M | ||
| Q1 25 | $135.2M | $142.0M | ||
| Q4 24 | $132.5M | $140.9M | ||
| Q3 24 | $131.8M | — | ||
| Q2 24 | $119.1M | $96.8M | ||
| Q1 24 | $120.9M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | 1.41× | 4.90× | ||
| Q2 24 | 0.83× | 3.08× | ||
| Q1 24 | 0.95× | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.2M | $908.0K |
| Free Cash FlowOCF − Capex | $6.1M | $692.0K |
| FCF MarginFCF / Revenue | 17.2% | 1.7% |
| Capex IntensityCapex / Revenue | 3.2% | 0.5% |
| Cash ConversionOCF / Net Profit | 3.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | $15.7M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.2M | $908.0K | ||
| Q3 25 | $13.8M | $-785.0K | ||
| Q2 25 | $-1.1M | $-3.5M | ||
| Q1 25 | $6.6M | $-17.0M | ||
| Q4 24 | $6.4M | $-8.6M | ||
| Q3 24 | $9.4M | $-5.4M | ||
| Q2 24 | $6.8M | $-5.0M | ||
| Q1 24 | $12.0M | $-12.0M |
| Q4 25 | $6.1M | $692.0K | ||
| Q3 25 | $10.2M | $-899.0K | ||
| Q2 25 | $-4.1M | $-3.8M | ||
| Q1 25 | $3.7M | $-17.2M | ||
| Q4 24 | $1.9M | $-8.7M | ||
| Q3 24 | $7.8M | $-5.8M | ||
| Q2 24 | $1.5M | $-5.6M | ||
| Q1 24 | $7.9M | $-12.4M |
| Q4 25 | 17.2% | 1.7% | ||
| Q3 25 | 29.4% | -2.4% | ||
| Q2 25 | -12.2% | -9.9% | ||
| Q1 25 | 10.9% | -53.8% | ||
| Q4 24 | 5.2% | -38.6% | ||
| Q3 24 | 21.8% | -31.3% | ||
| Q2 24 | 4.3% | -34.0% | ||
| Q1 24 | 22.4% | -71.1% |
| Q4 25 | 3.2% | 0.5% | ||
| Q3 25 | 10.4% | 0.3% | ||
| Q2 25 | 8.8% | 0.7% | ||
| Q1 25 | 8.9% | 0.7% | ||
| Q4 24 | 12.0% | 0.4% | ||
| Q3 24 | 4.5% | 2.1% | ||
| Q2 24 | 15.0% | 3.7% | ||
| Q1 24 | 11.7% | 2.2% |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 1.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
